Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Drug Take-Back Program

Program overview

The Oregon Department of Environmental Quality oversees the Drug Take-Back Program, which offers Oregon residents a convenient, safe, and secure way to dispose of unwanted prescription and over-the-counter medicines.

Find a participating drop-off site or get a mail-back envelope

Safe Drug Disposal website 
Toll-Free Telephone: 844-482-5322

​

January 2026: DEQ approves MED-Project USA to continue drug take-back program; Drug Takeback Solutions Foundation program to wind down

DEQ approved an updated plan by MED-Project for continued operation of its drug take-back program. 

This Updated Plan replaces the MED-Project plan that DEQ approved in 2021. 

The other program operator, the Drug Takeback Solutions Foundation, withdrew its updated plan and notified DEQ that it is winding down its program. The last day the Foundation program will operate as a state drug take-back program under the Drug Take-Back Law will be June 30, 2026.​​​

2025 Updated Plan Review

DEQ approved plans by two program operators in 2021 to operate drug take-back programs in Oregon. DEQ received updated plans from both program operators for the continued operation of their programs. These program operators also submitted variance requests or waivers because the program operators are unable to establish the number of drop-off sites required by statute.

For submissions and documents on 2021-2025 program implementation, see “2021-2025 Program implementation documents."

Public input on updated plans:

DEQ held a public input period on updated plans and received the following input:

Submissions by Drug Takeback Solutions Foundation:

October 2025: DEQ received the following submissions from the Foundation

August 2025: DEQ rejected the Foundation's Updated Plan for revision and rejected the Variance and Waiver Requests. The Foundation must submit a revised updated plan by Oct. 14, 2025.

July 2025: DEQ received an additional variance request from the Foundation

May 2025: DEQ received the following submissions from the Foundation

​Submissions by MED-Project USA:

October 2025: DEQ received the following submissions from MED-Project

August 2025: DEQ rejected MED-Project's Updated Plan for revision and rejected the Variance Request. MED-Project must submit a revised updated plan by Oct. 14, 2025.

May 2025: DEQ received the following submissions from MED-Project

Other news and updates

Enforcement (May 2025):

DEQ issued a Notice of Civil Penalty against the Drug Takeback Solutions Foundation for violations of the Drug Take-Back Law. Information on the enforcement action can be found on DEQ's Enforcement Actions web page.​

Why is safe medicine disposal important?

Leftover or expired medicines can pose several serious environmental and health risks. If not disposed, unused medicines can lead to accidental poisonings, addiction or abuse. Medicines can also have health and environmental impacts when they end up in a landfill or are flushed down the toilet or drain. Wastewater treatment plants and septic systems are usually not equipped to treat pharmaceuticals. Chemical compounds from these medicines can pass through treatment plants or septic systems to our rivers or groundwater. 

How does it work?

It's never been easier! The Drug Take-Back Program makes it more convenient to safely dispose of unwanted prescription and over-the-counter medicines in two ways. There is no charge for either service. 

  • Take your unwanted household medicines to a drop-off site: You can take your unwanted medicines to a participating drop-off site and dispose of them in the on-site secure repository.  You don't need to show ID or fill out any paperwork to use the drop-off site.
  • Mail-back: You can request and receive a pre-paid, pre-addressed envelope and mail in your unused medicines for disposal.

In communities underserved by drop-off sites, there may also be collection events or other services, such as locations where mail-back envelopes can be picked up in-person. 

Collection services are for household disposal, not pharmaceutical waste from businesses. Per ORS 459A.200, services are available to::

  • Oregon residents
  • Non-business entities in Oregon
  • Ultimate users, as defined by 21 U.S.C. 802(27)

Program services are not intended for law enforcement agencies or entities that generate pharmaceutical waste, such as a hospital, health care clinic, health care provider office, veterinary clinic or pharmacy.

Program services are provided by two program operators subject to the Drug Take-Back Law (Oregon Revised Statutes 459A.200 to 459A.266 and the Drug Take-Back rules in Chapter 340, Division 98) and with program plans approved by DEQ. DEQ provides administrative oversight for the programs and, in partnership with the Oregon Board of Pharmacy, monitors program operations for compliance. The Program is funded by drug manufacturers and free of charge to Oregon residents.

Note: Documents posted on this web page, including submissions by program operators, may contain redactions proposed to DEQ because the owner of the document has claimed confidentiality on the redacted information. DEQ has not evaluated these proposed redactions to determine whether such information is exempt from release to the public.

​​​​DEQ approved program plans for two program operators to implement drug take-back programs in Oregon: The Drug Takeback Solutions Foundation and MED-Project USA.

Program operators must operate their program in accordance with their approved program plans or changes as approved by DEQ pursuant to ORS 459A.212. Program operators must also submit annual reports on program performance.

Program plans

Annual reports

Program Year 4 (July 1, 2024 - July 30, 2025)

Program Year 3 (July 1, 2023 – June 30, 2024)

Program year 2 (July 1, 2022 – June 30, 2023)

Program year 1 (July 1, 2021 – June 30, 2022)

Approved variances:

Both program operators are currently unable to meet the number of drop-off sites required for Oregon by the Drug Take-Back Law. When a program operator is unable to establish or maintain the required number of drop-off sites, DEQ may approve the program operator to provide collection events and alternative services to ensure convenience service. DEQ considers a program operator's request to provide collection events and alternative services in lieu of drop-off sites to be a “variance request." 

DEQ is posting approved variance requests to provide collection events and alternative services for the program year beginning July 1, 2024: 

As an example of alternative services, a program operator may offer locations (known as “mail-back distribution locations or sites") where residents can pick up mail-back envelopes that they can use to mail off unwanted medicines for destruction. 

​

Manufacturers should familiarize themselves with the Drug Take-Back Law, including ORS 459A.203, which explains manufacturers' requirements for participating in a drug take-back program. Manufacturers should contact the program operators directly with inquiries on how to participate.

Under ORS 459A.203(2), a covered manufacturer is not required to participate in a drug take-back program if it provides sufficient proof to DEQ that it manufactures covered drugs for fewer than 50 patients in Oregon.

Exemptions:

For guidance on how to submit a claim of exemption, please see Section 1 of Guide for Oregon Drug Take-Back Programs.

The following manufacturers have claimed exemption from participating in a drug take-back program:

Parsolex GMP Center, Inc. (formerly Purdue GMP Center, Inc.)
3000 Kent Avenue, Suite C1-100
West Lafayette, IN 47906-1075

​

Pharmacies, law enforcement agencies and other potential authorized collectors, as defined in ORS 459A.200, have an opportunity to join a statewide program as authorized collectors and offer their communities a safe and secure way to dispose of unwanted drugs.

Authorized collectors will host collection kiosks for program operators. A program operator will service the kiosk for the authorized collectors, transport the pharmaceutical waste and ensure its proper disposal. Drug manufacturers are responsible for the cost of collection and disposal.

Examples of authorized collectors for a drug take-back program:​

  • A person who is registered with the Drug Enforcement Administration of the United States Department of Justice and qualifies under federal law to collect and dispose of controlled substances or qualifies under federal law to have the person's registration modified in such a way that authorizes the person to collect and dispose of controlled substances

  • A law enforcement agency

Potential authorized collectors interested in becoming a drop-off site can contact the program operators directly:​

​The Drug Takeback Solutions Foundation  

Shawn Canterbury
Director, Consumer Drug Take-Back
Email: shawn.canterbury@inmar.com
Phone: 800-350-0397, option #5

MED-Project USA
Dr. Victoria Travis, National Program Director
3439 NE Sandy Blvd, Unit 3620
Portland, OR 97232
Email: oregon@med-project.org
Phone: 833-633-7765 

In areas where a program operator is unable to establish a drop-off site, the program operator may seek DEQ approval to provide additional services or host collection events.

Local governments should contact program operators directly if they have questions about what the programs will offer in their jurisdiction, including possible additional services or collection events if drop-off sites are not established. ​




Contact